These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26743475)

  • 21. The status of microRNA-21 expression and its clinical significance in human cutaneous malignant melanoma.
    Jiang L; Lv X; Li J; Li J; Li X; Li W; Li Y
    Acta Histochem; 2012 Oct; 114(6):582-8. PubMed ID: 22130252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors.
    Xu Y; Brenn T; Brown ER; Doherty V; Melton DW
    Br J Cancer; 2012 Jan; 106(3):553-61. PubMed ID: 22223089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
    Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
    Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.
    Sondermann A; Andreghetto FM; Moulatlet AC; da Silva Victor E; de Castro MG; Nunes FD; Brandão LG; Severino P
    Clin Exp Metastasis; 2015 Aug; 32(6):521-30. PubMed ID: 26007293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
    Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
    Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
    Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
    Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.
    Koh SS; Wei JP; Li X; Huang RR; Doan NB; Scolyer RA; Cochran AJ; Binder SW
    Mod Pathol; 2012 Jun; 25(6):828-37. PubMed ID: 22411186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
    Wang K; Zhang ZW
    Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.
    Babapoor S; Horwich M; Wu R; Levinson S; Gandhi M; Makkar H; Kristjansson A; Chang M; Dadras SS
    Mod Pathol; 2016 May; 29(5):461-75. PubMed ID: 26916074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.
    Hilari JM; Mangas C; Xi L; Paradelo C; Ferrándiz C; Hughes SJ; Yueh C; Altomare I; Gooding WE; Godfrey TE
    Ann Surg Oncol; 2009 Jan; 16(1):177-85. PubMed ID: 18982394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma.
    Jikuzono T; Kawamoto M; Yoshitake H; Kikuchi K; Akasu H; Ishikawa H; Hirokawa M; Miyauchi A; Tsuchiya S; Shimizu K; Takizawa T
    Int J Oncol; 2013 Jun; 42(6):1858-68. PubMed ID: 23563786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
    Caramuta S; Egyházi S; Rodolfo M; Witten D; Hansson J; Larsson C; Lui WO
    J Invest Dermatol; 2010 Aug; 130(8):2062-70. PubMed ID: 20357817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
    Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
    Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification, Review, and Systematic Cross-Validation of microRNA Prognostic Signatures in Metastatic Melanoma.
    Jayawardana K; Schramm SJ; Tembe V; Mueller S; Thompson JF; Scolyer RA; Mann GJ; Yang J
    J Invest Dermatol; 2016 Jan; 136(1):245-254. PubMed ID: 26763444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of microRNA-205 expression is associated with melanoma progression.
    Liu S; Tetzlaff MT; Liu A; Liegl-Atzwanger B; Guo J; Xu X
    Lab Invest; 2012 Jul; 92(7):1084-96. PubMed ID: 22525428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.